Her research interests include adoptive cell therapy for the treatment of solid tumors, building on the backbone of success in patients with metastatic melanoma to investigate the strategy in patients with metastastic breast cancer. Her publications range from analysis of early trials of checkpoint blockade to genetic modifications of T-cell receptors.